An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk

Results from the Women's Health Initiative (WHI) trial support findings from observational studies that oestrogen–progestin therapy (EPT) use is associated with an increase in breast cancer risk. We conducted a meta-analysis using EPT-specific results from the Collaborative Group on Hormonal Fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S A, Ross, R K, Pike, M C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361783/
https://www.ncbi.nlm.nih.gov/pubmed/15900297
http://dx.doi.org/10.1038/sj.bjc.6602617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361783/
https://www.ncbi.nlm.nih.gov/pubmed/15900297
http://dx.doi.org/10.1038/sj.bjc.6602617

Ejemplares similares